© PR Newswire
08.01.2026
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder
News Preview
WASHINGTON, Jan. 8, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received a decision letter from the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) concluding that the supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon) for the treatment...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
VKTX
LISTED
NASDAQ
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity
News Preview
Study is Evaluating Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens Designed to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies f...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
INMD
LISTED
NASDAQ
InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M
News Preview
Conference call to be held on Tuesday, February 10, 2026, at 8:30 a.m. Eastern TimeYOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year of 2025 before the Nasdaq ma...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
08.01.2026
CRMD
LISTED
NASDAQ
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
News Preview
‒ Q4 2025 Unaudited Net Revenue of Approximately $127 million ‒...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
08.01.2026
NDTP
LISTED
OTC
NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant
News Preview
NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
COLL
LISTED
NASDAQ
Collegium Provides 2026 Financial Guidance and Business Update
News Preview
– Product Revenues, Net Expected in the Range of $805 Million to $825 Million –...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
KRRO
LISTED
NASDAQ
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 10:30 a.m. PT (1:30 p.m. ET). Todd Chappell, Chief Operating Officer, and Loic...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
BRKR
LISTED
NASDAQ
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of an additional 60% ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker’s ownership to 100%. The transaction adds ultra-fast TOF-MS technology for small...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
CGC
LISTED
NASDAQ
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has entered into a series of transactions to recapitalize its balance sheet and extend the maturity dates of all outstanding indebt...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
XERS
LISTED
NASDAQ
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue
News Preview
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2025, and other highlights.
"Our fourth quarter performance capped off a truly transformative 2025. Recorlev® delivered exceptional results, outperforming expectations and further strengthening the momentum...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
NEOG
LISTED
NASDAQ
Neogen Announces Second-Quarter 2026 Results
News Preview
Neogen Corporation (NASDAQ: NEOG) announced today the results of the second quarter ended November 30, 2025.
“I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic transformation with early work focused on stabilizing and strengthening our core business. While it is early in the process, and our indust...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced updates on its research and development programs and highlighted upcoming key milestones for 2026.
“Building on the progress we achieved in our RSV and immun...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
08.01.2026
AMLX
LISTED
NASDAQ
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
News Preview
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the selection of AMX0318, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist, as a development candidate for post-bariatric hypoglycemia (PBH) and other rare diseases. AMX0318 was identified through a research collaboration with Gubra A/S (“Gubra...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
EPRX
LISTED
TSX
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy
News Preview
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improve...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
AVXL
LISTED
NASDAQ
Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology
News Preview
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, an...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
VERA
LISTED
NASDAQ
Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Vera Therapeutics to participate in the 44th Annual J.P. Morgan Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ZVRA
LISTED
NASDAQ
Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
News Preview
CELEBRATION, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will present at the J.P. Morgan 44th Annual Healthcare Conference i...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ENOV
LISTED
NYSE
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Dallas, TX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 44th Annual J.P. Morgan Healthcare Conference with a presentation scheduled for Monday, January 12th, 2026, at 4:30 p.m. PST (7:30 p.m. ES...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
IVVD
LISTED
NASDAQ
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
News Preview
NEW HAVEN, Conn., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced preliminary fourth quarter (Q4) revenue and recent business highlights....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
AVIR
LISTED
NASDAQ
Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
CGEM
LISTED
NASDAQ
Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones
News Preview
Data readouts planned for CLN-978 across all three autoimmune indications in 2026, including single dose and repeat dosing data...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
CLYM
LISTED
NASDAQ
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
News Preview
First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 ...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
INDV
LISTED
NASDAQ
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
News Preview
RICHMOND, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Indivior PLC (Nasdaq: INDV) (“Indivior PLC” or the “Company”) today announced its full-year 2026 financial guidance....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ATAI
LISTED
NASDAQ
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
News Preview
AtaiBeckley provides its outlook for 2026 ahead of attendance at the J.P. Morgan 44th Annual Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
JSPR
LISTED
NASDAQ
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
News Preview
67% of additional patients (n=6) enrolled in the BEACON study achieved a complete response at 12 weeks with a mean UAS7 reduction of 31 points ...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
LXEO
LISTED
NASDAQ
Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy
News Preview
Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
TRDA
LISTED
NASDAQ
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
News Preview
Entrada Therapeutics reports progress across its portfolio of RNA-based programs for the potential treatment of neuromuscular and ocular diseases....
Themefolio
Profiler
Peergroup
© Newsfile
08.01.2026
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness Announces Grand Opening of Its 31st Location in Red Deer, Alberta
News Preview
Toronto, Ontario--(Newsfile Corp. - January 8, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce the grand opening of Heal Wellness ("Heal") in Red Deer, Alberta, this Saturday January 10th, marking the brand's 31st operating...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
NGEN
LISTED
TSX
NervGen Pharma Begins Trading on Nasdaq Today
News Preview
NervGen Pharma's common shares have been approved for listing on Nasdaq and will begin trading today, under the symbol "NGEN"...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
TFX
LISTED
NYSE
Teleflex Announces Leadership Transition
News Preview
Stuart Randle Appointed Interim President and CEO...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ACON
LISTED
NASDAQ
Aclarion Provides 2025 Update and 2026 Corporate Outlook
News Preview
Aclarion Provides 2025 Update and 2026 Corporate Outlook...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
TLX
LISTED
ASX
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA (U.S.). ...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
KDEV
LISTED
STO
Karolinska Development’s Extraordinary General Meeting 2026
News Preview
STOCKHOLM, SWEDEN – January 8, 2026. Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held an Extraordinary General Meeting on January 8, 2026, at which the shareholders resolved as follows....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ORNBV
LISTED
HEL
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
News Preview
ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET ...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
08.01.2026
MDCE
LISTED
OTC
$50K Michael Jordan Jersey turns into a $4.5M Jackpot Discovery using Real Game Used's Patent Pending AI Technology
News Preview
MESA, ARIZONA / ACCESS Newswire / January 8, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its wholly owned subsidiary, Real Game Used (RGU), has identified what is believed to be a 1985-86 Chicago Bulls game-worn road jersey attributed to Michael Jordan through the company's patent-pending AI image-analysis and search...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
RKV
LISTED
TSX
Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors
News Preview
VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina”), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery and Variational AI, a leader in generative artificial intelligence for small-molecule design, today announced the expan...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
08.01.2026
LOBE
LISTED
CSE
Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
News Preview
Balance Sheet and Sharpened Strategy VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 8, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases with unmet medical needs, today reported audited financial results for the fisca...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
08.01.2026
POROF
LISTED
OTC
Cellev8 Nutrition Welcomes Dr. Guangshuo "Alan" Zhu, MD to Its Board of Directors
News Preview
WELLINGTON, FLORIDA / ACCESS Newswire / January 8, 2026 / Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant and cellular nutrition solutions, proudly announces the appointment of Dr. Guangshuo "Alan" Zhu, MD to its Board of Directors. Dr. Zhu brings decades of groundbreaking experience in cardiovascular med...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
08.01.2026
TIVC
LISTED
NASDAQ
Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines
News Preview
Conference Call to be Hosted on Monday, January 12 at 1:30 PM PT/4:30 PM ET FREMONT, CA / ACCESS Newswire / January 8, 2026 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that Management will host a special conference call to further discuss the company's recent acquisition of certain cont...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
BAYN
LISTED
XETR
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
News Preview
Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaboration and global licensing agreement to advance a heart-targeted small interfering RNA (siRNA) therapy. The companies will collaborate to develop a siRNA-based treatment for a form of dila...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
45650
LISTED
XJPX
Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
News Preview
Tokyo, Japan and Cambridge, UK, 8 January 2026 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces that it has entered an exclusive licensing agreement for the development, manufacturing and commercialization of vamorolone for the treatment of Duchenne Muscular Dystrophy (DMD) in Japan, South Korea, Australia and New Zealand...
Themefolio
Profiler
Peergroup
© EQS Newswire
08.01.2026
EVT
LISTED
XETR
Just – Evotec Biologics erhält Förderung für KI-gestützte Optimierung der Entwicklungsfähigkeit monoklonaler Antikörper zur Verbesserung des bezahlbaren Zugangs
News Preview
Just – Evotec Biologics wird monoklonale Antikörper und andere biologische Modalitäten optimieren
Die Investition ermöglicht in den nächsten drei Jahren zehn neue J.MD™-Projekte zur molekularen Optimierung; darin inbegriffen, aber nicht beschränkt auf: verbesserte Titer, Pharmakokinetik, Immunogenität und Stabilität
Hamburg, 0......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.01.2026
EVT
LISTED
XETR
Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
News Preview
Just – Evotec Biologics will optimize monoclonal antibodies (“mAbs”) and other biologic modalities
Investment enables ten new J.MD™ projects encompassing molecular optimization including, but not limited to: improved titer, pharmacokinetics, immunogenicity, and stability, over the next three years
Hamburg, Germany, January 08,......
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
OGN
LISTED
NYSE
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway
News Preview
Organon today announced that it has entered into an agreement with Daiichi Sankyo Europe to commercialize Nilemdo® (bempedoic acid) in France, Denmark, Iceland, Sweden, Finland and Norway. Nilemdo® is a new, first-in-class drug indicated for patients with high cholesterol and cardiovascular disease risk. It provides an alternative treatment for pa...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
SANN
LISTED
SIX
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
08.01.2026
AIML
LISTED
CSE
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
News Preview
Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow.Partnership introduces CardioYield™ powered by MaxYield™ for automated, reliable Holter analysis. TORONTO, ON / ACCESS Newswire / January 8, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
BSLN
LISTED
SIX
Basilea provides portfolio update and outlook
News Preview
Allschwil, Switzerland, January 08, 2026...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the pricing of its concurrent public offerings of (i) $625,000,000 aggregate principal amount of 0.00% convertible senior notes due 2032 (the “notes”) and (ii) 3,100,776 shares of common stock, at a public offering price of $64.50 per share (or, in lieu of shares of common stock to cer...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ALMS
LISTED
NASDAQ
Alumis Announces Pricing of Upsized Public Offering of Common Stock
News Preview
Alumis Announces Pricing of Upsized Public Offering of Common Stock...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
PHAT
LISTED
NASDAQ
Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
News Preview
FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the pricing of an underwritten public offering of 6,875,000 shares of its common stock and pre-funded warrant...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
CNVI
LISTED
TSX
Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus
News Preview
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
DRUG
LISTED
NASDAQ
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
News Preview
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces the pricing of its previously announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares”) at a price of $90.00 per Common Share for anticipated gross proceeds...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
AVNS
LISTED
NYSE
Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, Jan. 13, at approximately 2:15 p.m. PST....
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
KOD
LISTED
NASDAQ
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
News Preview
PALO ALTO, Calif., Jan. 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that senior management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA ...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
VEEV
LISTED
NYSE
Novo Nordisk International Operations Commits to Veeva Vault CRM
News Preview
Chooses industry leading Vault CRM to empower commercial teams with next-generation CRM capabilities and agentic AISINGAPORE, Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Novo Nordisk's International Operations business unit has committed to use Veeva Vault CRM....
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
CORT
LISTED
NASDAQ
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or “the Company”) (NASDAQ: CORT) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
08.01.2026
EVT
LISTED
XETR
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
News Preview
Just - Evotec Biologics will optimize monoclonal antibodies ("mAbs") and other biologic modalitiesInvestment enables ten new J.MD™ projects encompassing molecular optimization including, but not limited to: improved titer, pharmacokinetics, immunogenicity, and stability, over the next three years HAMBURG, DE / ACCESS Newswire / Janu...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
HAE
LISTED
NYSE
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
News Preview
BOSTON, Jan. 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, February 5, 2026. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 5,...
Themefolio
Profiler
Peergroup
© Newsfile
08.01.2026
MYTC
LISTED
CSE
MyndTec Inc. Completes Additional Tranche of Non-Brokered Private Placement
News Preview
Mississauga, Ontario--(Newsfile Corp. - January 7, 2026) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed an additional tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offer...
Themefolio
Profiler
Peergroup
© Newsfile
07.01.2026
EPIC
LISTED
CSE
1CM Announces CFO Change
News Preview
Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM" or the "Company") is pleased to announce that its board of directors has appointed Antony Pramoth as Chief Financial Officer of the Company. Mr. Pramoth succeeds Harshil Chovatiya, who has served as the Company's Chief Financial Officer sin...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
